Cyanotech

Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye, joint, and immune health, and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. The company was founded by Gerald R. Cysewski in 1983 and is headquartered in Kailua-Kona, HI.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Cyanotech Reports Mixed Q4 Results, Strategic Shifts Ahead

Cyanotech's fiscal year 2024 concluded with mixed results, marked by a slight decrease in annual sales and increased losses, despite growth in Q4 sales. Strategic initiatives including product diversification and marketing overhaul are in place to address the challenges of price sensitivity and competitive pressures. The company's financial health shows strain with reduced cash and working capital compared to the previous year.

Cyanotech reports 15% sales growth in Q1 2025 earnings call

Cyanotech's Q1 2025 saw revenue growth but faced gross profit decline and a net loss. The company is addressing production challenges and focusing on operational efficiency. Introduction of new products like Hawaiian Spirulina gummies showcases innovation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CYAN (CYAN, Financial), a company listed on the U.S. OTC market, experienced a significant stock price increase of 6.58%. The stock is currently trading at $0.81 per share with a trading volume of 6,855 shares and a turnover rate of 0.10%.

CYAN Stock Surges 6.58% on U.S. OTC Market Amid Sector Decline

KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for Q1FY25.

Cyanotech Reports Financial Results for the First Quarter of Fiscal 2025

KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for Q4FY24 and Fiscal Year 2024.

Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2024

Cyanotech Corporation (NASDAQ:CYAN ) Q3 2024 Results Conference Call February 9, 2024 8:00 PM ET Company Participants Matt Custer - President and CEO Felicia Ladin - CFO Matt Custer Aloha from Kona, Hawaii. Thank you all for joining us today.

Cyanotech Corporation (CYAN) Q3 2024 Earnings Call Transcript

KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for Q3FY24.

Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2024

KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2024.

Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2024

KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the First Quarter of Fiscal 2024.

Cyanotech Reports Financial Results for the First Quarter of Fiscal 2024

KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Corporation Positions for Accelerated Global Growth in Microalgae Market with Key Leadership Appointment.

Cyanotech Corporation Positions for Accelerated Global Growth in Microalgae Market with Key Leadership Appointment

KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2023.

Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2023

Better Choice Co

Rite Aid

Veru

Vintage Wine Estates

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

Top 5 Defensive Stocks That Are Set To Fly

KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the third quarter and first nine months of fiscal year 2023, ended December 31, 2022.

Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2023

KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2023

Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2023

Liquidia Technologies Inc

The New Board Members Will Bring Industry Experience to Contribute to Company Growth WOODINVILLE, Wash. , Nov. 2, 2022 /PRNewswire/ -- Anavasi Diagnostics ('Anavasi'), an NIH/RADx medical technology company focused on the development of novel molecular diagnostic testing, recently announced the election of three new outside members to its Board of Directors, Bryan Crane, PhD, Arthur Kirsch, and David Vied.

ANAVASI DIAGNOSTICS ANNOUNCES NEWLY ELECTED OUTSIDE BOARD OF DIRECTORS

Barnwell Industries

CVD Equipment

A handful of past VBR picks are becoming net asset turnaround ideas on price weakness. Ultra-low price to tangible book value and EV to EBITDA readings are entering bargain territory.

3 Small-Cap Bargains: Volume Breakout Report Update

KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Corporation, a world leader in microalgae-based, high-value nutrition and dietary supplement products, announced results for 1Q fiscal 2023.

Cyanotech Reports Financial Results for the First Quarter of Fiscal 2023

Fresh Del Monte Produce

LGL Group

Li Auto Inc.

Grand Canyon Education

Nathan's Famous

I am looking for ways to report on my quant formula sorting results in quicker fashion for readers. The Volume Reversal Report intends to highlight the past week's most interesting high-volume gainers I can find.

Volume Breakout Report: June 25, 2022

KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Corporation, a world leader in microalgae-based, high-value nutrition supplement products, announced financial results for fiscal year 2022

Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2022

Cyanotech is getting new wholesale orders for bulk microalgae production in Hawaii.

The ESG Future Of Food Protein Production: Cyanotech

KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2022

Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2022

KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2022

Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2022

KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the First Quarter of Fiscal 2022

Cyanotech Reports Financial Results for the First Quarter of Fiscal 2022

KAILUA KONA, Hawaii--(BUSINESS WIRE)--Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2021

Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2021

China Pharma Holdings

SeaChange International

Universe Pharmaceuticals

Shares of several penny stocks are on the rise today as Reddit investors continue to pick out the top ones to take a risk on. The post Top Penny Stocks Today: What to Know About BAYP, SEAC, UPC, CPHI, CYAN Stocks appeared first on InvestorPlace.

Top Penny Stocks Today: What to Know About BAYP, SEAC, UPC, CPHI, CYAN Stocks

Cyanotech Corporation (NASDAQ: CYAN) reported fourth-quarter net sales of $30.2 million in fiscal 2019 compared to $34.1 million in 2018.

News for Cyanotech Stock (CYAN)